Capricor Therapeutics (CAPR) Prepaid Assets (2010 - 2026)
Capricor Therapeutics (CAPR) recorded quarterly Prepaid Assets of $4.5 million in Q1 2026, down 5.74% quarter-over-quarter from $4.8 million in Q4 2025, and up 216.81% on a YoY basis from $1.4 million in Q1 2025.
Capricor Therapeutics (CAPR) Prepaid Assets (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 216.81% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 216.81% YoY), while the FY2025 annual figure was $4.8 million, up 216.59% from the prior year.
- Prepaid Assets was $4.5 million for Q1 2026 at Capricor Therapeutics, down from $4.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.8 million in Q4 2025 to a low of $343684.0 in Q3 2022.
- Historically, Prepaid Assets has averaged $1.4 million across 5 years, with a median of $943246.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets dropped 20.69% in 2022, then surged 504.19% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $919892.0 in 2022, then grew by 8.25% to $995776.0 in 2023, then jumped by 50.73% to $1.5 million in 2024, then surged by 216.59% to $4.8 million in 2025, then slipped by 5.74% to $4.5 million in 2026.
- The last three Prepaid Assets figures came in at $4.5 million (Q1 2026), $4.8 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.48 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 385,065.00 |
| Jun 30, 2024 | 837,218.00 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 995,776.00 |
| Sep 30, 2023 | 458,417.00 |
| Jun 30, 2023 | 583,835.00 |
| Mar 31, 2023 | 875,092.00 |
| Dec 31, 2022 | 919,892.00 |
| Sep 30, 2022 | 343,684.00 |
| Jun 30, 2022 | 659,269.00 |
| Mar 31, 2022 | 943,246.00 |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | 278,909.00 |
| Jun 30, 2021 | 653,336.00 |